Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $514.2200 (1.05%) ($508.7750 - $514.9100) on Wed. Jun. 3, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.7% (three month average) | | RSI | 76 | | Latest Price | $514.2200(1.05%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | REGN advances 1.9% a week on average for past two weeks. | | Market Behavior | Value stock rally for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(47%) XLV(37%) XBI(36%) QQQ(30%) SPY(29%) | | Factors Impacting REGN price | REGN will decline at least -0.85% in a week (0% probabilities).
VIXM(-12%) TLT(-6%) SHY(-3%) UUP(-2%) IGOV(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.85% (StdDev 1.7%) | | Hourly BBV | 0 () | | Intraday Trend | 0.9% | | | | | |
|
| 5 Day Moving Average | $512.32(0.37%) | | 10 Day Moving Average | $512.6(0.32%) | | 20 Day Moving Average | $499.05(3.04%) | | To recent high | -0.3% | | To recent low | 24.7% | | Market Cap | $54.522b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |